ARCHIVES

FDA Begins To Examine Its Role In Allowing Misleading Consumer Advertising.

This article is from The Cancer Letter archive.

Vol. 33 No. 19 | May 18, 2007

Download PDF Visit The Full Archive

Related Articles

Stanford Group Working To Build ‘Superhighway’ To Synthesis Of Taxol

May 15, 1992

NCI Programs: NCI Seeks Nominations For director’s Consumer Liaison Group

August 6, 1999

DCCP Board Approves Concepts For Nearly $20 Million In Grants, Contracts, Including New Inhibitors Study

June 10, 1983

Also in this 8-page issue: NCI closes its Tobacco Intervention Research Clinic, blaming flat budget, slow accrual.

October 15, 2004

Scrutiny of caBIG Exposes Conflicts, Bonanza For Contractors

March 18, 2011

New Subcommittee Chairman Named

June 10, 1977